Metabolic biomarkers for early diagnosis and recurrence of colorectal cancer
Part of Cancer, Digestive system clinical trials.
This study looks at metabolic biomarkers in blood and tumor tissue to help detect colorectal cancer earlier, predict outcomes, and monitor for recurrence. It includes both people newly diagnosed with colorectal cancer and healthy volunteers for comparison.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- For colorectal cancer group: You have been diagnosed with colorectal adenocarcinoma confirmed by biopsy, and have not yet received any anti-cancer treatment.
- For colorectal cancer group: You must have tumor tissue and blood samples available to submit.
- You do not have a family history of hereditary colorectal cancer.
- You do not have poorly controlled chronic conditions like high blood pressure, diabetes, or inflammatory bowel disease.
- You have not taken antibiotics, probiotics, or immunosuppressants recently (within the past month or six months).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if a simple blood test can detect early signs of colorectal cancer coming back after surgery to remove cancer spread in the abdomen. It may help patients avoid unnecessary treatments and catch recurrence sooner.
This study is looking for people newly diagnosed with colorectal cancer or advanced adenoma to help find better ways to detect the disease early using advanced lab tests on blood samples.
This study aims to improve early diagnosis and track recurrence of colorectal cancer. It involves different groups of people, including those with colorectal cancer, those with benign bowel conditions, and healthy volunteers, to develop better prediction tools.
This study looks at special tiny cell-signal particles (called exosomes) and related pathways to understand colorectal cancer. Your results from samples may help researchers learn how these signals relate to the disease after surgery.
This study looks at how early-onset colorectal cancer treatment affects reproductive and sexual health over time. It asks eligible people to complete questionnaires so researchers can understand and possibly improve care during and after treatment.
This study aims to improve detection of colorectal cancer in people diagnosed before age 50. It compares samples from patients with cancer to those without to find new early detection methods.
Hear when a new Colorectal cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.